Grant

Biomarkers for multiple sclerosis

Patent Number US-11994519-B2

Publication Year 2024

Granted Year: 2024

Application Year 2018

Priority Year 2017

Jurisdiction US

Status Active

Inventors

VALLE BRIAN WILLIAM DELLA HEMPEL CASPER LARSEN MARIE AGNETE

Applicants

  1. Glx Analytix Aps

Abstract

The present invention relates to biomarkers associated with multiple sclerosis (MS), particular GLX molecules, and teven more particular GLX-related glycosaminoglycans (GAGs) and GLX-related proteoglycans (PGs).

Patent Family Records (4)

Biomarkers for multiple sclerosis

Glx Analytix Aps VALLE BRIAN WILLIAM DELLA, HEMPEL CASPER, LARSEN MARIE AGNETE

2024, US-11994519-B2

BIOMARKERS FOR MULTIPLE SCLEROSIS  

Glx Analytix Aps VALLE BRIAN WILLIAM DELLA, HEMPEL CASPER, LARSEN MARIE AGNETE

2020, EP-3724660-A1

BIOMARKERS FOR MULTIPLE SCLEROSIS  

HEMPEL CASPER, LARSEN MARIE AGNETE, VALLE BRIAN WILLIAM DELLA VALLE BRIAN WILLIAM DELLA, HEMPEL CASPER, LARSEN MARIE AGNETE

2019, WO-2019115724-A1

BIOMARKERS FOR MULTIPLE SCLEROSIS  

Glx Analytix Aps VALLE BRIAN WILLIAM DELLA, HEMPEL CASPER, LARSEN MARIE AGNETE

2019, CA-3087305-A1

Data Provider: Digital Science

LINKS
-

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+